Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480–508.
Article
Google Scholar
Weber WA. Use of PET for Monitoring Cancer Therapy and for Predicting Outcome. J Nucl Med. 2005;46:983–95.
CAS
PubMed
Google Scholar
Borst GR, Belderbos JS, Boellaard R, EFI C, De Jaeger K, Lammertsma A, et al. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer. 2005;41:1533–41.
Article
Google Scholar
Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma AA, et al. Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials. J Nucl Med. 2006;47:1059–66.
CAS
PubMed
Google Scholar
Gupta T, Master Z, Kannan S, Agarwal JP, Ghsoh-Laskar S, Rangarajan V, et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:2083.
Article
Google Scholar
Ung YC, Maziak DE, Vanderveen JA, Smith CA, Gulenchyn K, Lacchetti C, et al. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: A systematic review. J Natl Cancer Inst. 2007;99:1753–67.
Article
Google Scholar
Liao S, Penney BC, Wroblewski K, Zhang H, Simon CA, Kampalath R, et al. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2012;39:27–38.
Article
CAS
Google Scholar
Weber WA. Assessing Tumor Response to Therapy. J Nucl Med. 2009;50:1S–0.
Article
CAS
Google Scholar
Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50(Suppl 1):11S–20S.
Article
CAS
Google Scholar
Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med. 2004;45:1431–4.
PubMed
Google Scholar
Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol United States. 2010;195:310–20.
Article
Google Scholar
Fahey FH, Kinahan PE, Doot RK, Kocak M, Thurston H, Poussaint TY. Variability in PET quantitation within a multicenter consortium. Med Phys United States. 2010;37:3660–6.
Google Scholar
Beyer T, Czernin J, Freudenberg LS. Variations in clinical PET/CT operations: results of an international survey of active PET/CT users. J Nucl Med United States. 2011;52:303–10.
Article
Google Scholar
Boellaard R. Need for standardization of 18F-FDG PET/CT for treatment response assessments. J. Nucl. Med. [Internet]. 2011;52 Suppl 2:93S-100S. Available from: http://jnm.snmjournals.org/content/52/Supplement_2/93S.full
Article
Google Scholar
Westerterp M, Pruim J, Oyen W, Hoekstra O, Paans A, Visser E, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: Effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging. 2007;34:392–404.
Article
Google Scholar
Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2014;42:328–54.
Article
Google Scholar
Delbeke D, Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel B, et al. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885–95.
PubMed
Google Scholar
Graham MM, Wahl RL, Hoffman JM, Yap JT, Sunderland JJ, Boellaard R, et al. Summary of the UPICT protocol for 18F-FDG PET/CT imaging in oncology clinical trials. J Nucl Med. 2015;56:955–61.
Article
Google Scholar
Scheuermann JS, Saffer JR, Karp JS, Levering AM, Siegel A. Qualification of PET Scanners for Use in Multicenter Cancer Clinical Trials: The American College of Radiology Imaging Network Experience. J Nucl Med. 2010;50:1187–93.
Article
Google Scholar
Kinahan P, Wahl R, Shao L, Frank R, Perlman E. The QIBA profile for quantitative FDG-PET/CT oncology imaging. J Nucl Med. 2014;55:1520.
Google Scholar
Sunderland JJ, Christian PE. Quantitative PET/CT Scanner Performance Characterization Based Upon the Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network Oncology Clinical Simulator Phantom. J Nucl Med. 2015;56:145–52.
Article
Google Scholar
Kaalep A, Sera T, Oyen W, Krause BJ, Chiti A, Liu Y, et al. EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems. Eur J Nucl Med Mol Imaging European Journal of Nuclear Medicine and Molecular Imaging. 2018;45:412–22.
Article
CAS
Google Scholar
van der Vos CS, Koopman D, Rijnsdorp S, Arends AJ, Boellaard R, van Dalen JA, et al. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET. Eur J Nucl Med Mol Imaging European Journal of Nuclear Medicine and Molecular Imaging. 2017;44:4–16.
Article
Google Scholar
Kuhnert G, Boellaard R, Sterzer S, Kahraman D, Scheffler M, Wolf J, et al. Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis. Eur. J. Nucl. Med. Mol. Imaging [Internet]. 2016;43:249–58. Available from: https://doi.org/10.1007/s00259-015-3165-8
Article
Google Scholar
Barrington SF, Sulkin T, Forbes A, Johnson PWM. All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting. Eur. J. Nucl. Med. Mol. Imaging [Internet]. 2018;45:316–7. Available from: https://doi.org/10.1007/s00259-017-3893-z
Article
Google Scholar
Kaalep A, Sera T, Rijnsdorp S, Yaqub M, Talsma A, Lodge MA, et al. Feasibility of state of the art PET/CT systems performance harmonisation. Eur J Nucl Med Mol Imaging European Journal of Nuclear Medicine and Molecular Imaging. 2018;45:1344–61.
Article
Google Scholar
Lasnon C, Salomon T, Desmonts C, Dô P, Oulkhouir Y, Madelaine J, et al. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction. Ann Nucl Med. 2017.
Boellaard R. Quantitative oncology molecular analysis suite: ACCURATE. J. Nucl. Med. [Internet]. 2018;59:1753. Available from: http://jnm.snmjournals.org/content/59/supplement_1/1753.abstract
EANM EARL website [Internet]. Available from: http://earl.eanm.org
Frings V, van Velden FHP, Velasquez LM, Hayes W, van de Ven PM, Hoekstra OS, et al. Repeatability of Metabolically Active Tumor Volume Measurements with FDG PET/CT in Advanced Gastrointestinal Malignancies: A Multicenter Study. Radiology [Internet]. Radiological Society of North America; 2014;273:539–48. Available from: https://doi.org/10.1148/radiol.14132807
Article
Google Scholar
Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009.
Cheebsumon P, Yaqub M, Van Velden FHP, Hoekstra OS, Lammertsma AA, Boellaard R. Impact of [ 18F]FDG PET imaging parameters on automatic tumour delineation: Need for improved tumour delineation methodology. Eur J Nucl Med Mol Imaging. 2011.
Armstrong IS, Kelly MD, Williams HA, Matthews JC. Impact of point spread function modelling and time of flight on FDG uptake measurements in lung lesions using alternative filtering strategies. EJNMMI Phys. 2014;1:99.
Article
Google Scholar
Ly J, Minarik D, Edenbrandt L, Wollmer P, Trägårdh E. The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations. EJNMMI Res. 2019.